ChemoTech: Funding, Investors & Team (Sep 2026)
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
ChemoTech has raised $1.6M across 4 funding rounds on record, the most recent an undisclosed round of $640k announced in Jun 2026.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
ChemoTech Company Profile and Key Stats
Latest funding round on record: Jun 2026.
ChemoTech Funding Rounds
ChemoTech raised $100k in a Post-IPO Equity announced in Mar 2022.
5 months later, a Post-IPO Debt of $240k was announced in Aug 2022.
11 months later, an undisclosed round of $580k was announced in Jul 2023.
2.9 years later, an undisclosed round of $640k was announced in Jun 2026.
ChemoTech Founders and Leadership Team
No contact details are on record for this team yet.
ChemoTech Funding Compared to Other Health Care Startups
ChemoTech's latest round of $640k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ChemoTech in Health Care and Lund
Companies Similar to ChemoTech
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
ChemoTech Funding FAQs
What does ChemoTech do?
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care through genuine research and clinical trials.
How much funding has ChemoTech raised?
ChemoTech has raised $1.6M across 4 rounds on record. The most recent is an undisclosed round of $640k announced in Jun 2026.
When did ChemoTech last raise funding?
ChemoTech's most recent funding round on record is an undisclosed round of $640k, announced in Jun 2026.
Who founded ChemoTech?
FundedIQ lists Shyam Garg (Founder) at ChemoTech.
Who is the CEO of ChemoTech?
Mohan Frick is listed as CEO at ChemoTech.
Where is ChemoTech headquartered?
ChemoTech is based in Lund, Skane Lan, Sweden.
How many employees does ChemoTech have?
ChemoTech is in the 1-10 employee band.
How does ChemoTech's funding compare to other Health Care startups?
ChemoTech's latest round of $640k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's ChemoTech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ChemoTech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.